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Abstract 
Objectives: The purpose of the present study was to develop an animal model for creating alveolar cleft defects 
with properly simulated clinical defect environment for tissue-engineered bone-substitute materials testing without 
compromising the health of the animal. Cleft creation surgery was aimed at creating a complete alveolar cleft with a 
wide bone defect with an epithelial lining (oral mucosa) overlying the cleft defect.
Methods: A postmortem skull of a New Zealand White (NZW) rabbit skull (Oryctolagus cuniculus) underwent an 
osteological and imaging survey. A pilot postmortem surgery was conducted to confirm the feasability of a surgical 
procedure and the defect was also radiologically confirmed and illustrated with micro-computed tomography. Then, 
a surgical in vivo model was tested and evaluated in 16 (n = 16) 8-week-old NZW rabbits to create in vivo alveolar 
cleft creation surgery.
Results: Clinical examination and imaging analysis 8 weeks after cleft creation surgery revealed the establishment of 
a wide skeletal defect extending to the nasal mucosa simulating alveolar clefts in all of the rabbits.
Conclusions: Our surgical technique was successful in creating a sizable and predictable model for bone grafting 
material testing. The model allows for simulating the cleft site environment and can be used to evaluate various bone 
grafting materials in regard to efficacy of osteogenesis and healing potential without compromising the health of the 
animal.
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Background
Congenital alveolar cleft is a malformation occurring as a 
result of non-fusion of primary palate during weeks 4–12 
of gestation. The goal of alveolar cleft repair is to establish 
bony continuity of the alveolar ridge in the maxilla, seal 
the communication oro-nasal communication, and create 
a favorable anatomy for dental rehabilitation [1–3]. Recon-
struction of the these defects is done via the alveolar cleft 
bone grafting procedure using autologous bone, allogenic 
and xenogeneic bone grafting materials, along with various 
tissue-engineered bone replacement materials [4–8].
Optimising the quality of the existing bone graft-
ing materials and looking for novel and better 
bone-substitute materials is crucial in improving the clin-
ical outcome. Experimental testing of various grafting 
materials requires the pre-establishment of a proper bio-
logical model to conduct experimental studies and eval-
uate the clinical effect with respect to osteogenesis and 
healing. Animal models with simulated alveolar clefts 
are considered appropriate as an experimental model 
for testing of clinical interventions. Several animal mod-
els have been utilized for testing of alveolar cleft grafting 
materials including mice, rats, rabbits, cats, dogs, swines, 
goats, sheep and monkeys [4, 9–24].
Development of alveolar clefts in experimental animals 
can be achieved, either surgically created or congeni-
tally induced in utero during embryonic development 
[19, 25–27]. Previous studies on in utero congenitally 
induced models reported increased need of technical 
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an increased incidence of intrauterine fetal death and 
abortions. In addition, several studies reported that new-
born animal models with lip defects were less cared by 
their mothers and some being subjected to cannibalism 
[28–30]. Next to congenitally induced models, surgically 
created alveolar clefts in animals also seem suitable to 
experimental studies regarding histologic and biome-
chanical properties of bone grafting material.
Moreover, it is essential to allow proper timing for 
healing of the defect and establish an alveolar cleft of 
appropriate width mimicking the human scenario of 
a skeletal defect extending to the nasal mucosa and the 
adjacent teeth and be suitable for clinical testing. Some 
earlier reported cleft models do not correspond to the 
clinical situation since a bone defect is created and filled 
in the same session. This is not in accordance to the real 
situation in which the defect is covered by epithelial lin-
ing. Hence, it is important to achieve a bony cleft with 
its surfaces covered with healthy mucosal tissue at the 
time of placement of graft. For this reason it is necessary 
to first create the bone defect and then in a second stage 
surgery, after healing with mucosal lining of the cleft has 
been achieved, place the grafting material, otherwise the 
defect is not corresponding to the real clinical situation. 
Moreover, compared with congenitally induced alveolar 
clefts, surgically created cleft models in animals can eas-
ily be created and allow for controlling the size and extent 
of the bony cleft and properly position the overlying soft 
tissue to serve the purpose of the model.
Animals used in biomaterial bone research include 
small animals, such as mice, rats, guinea pigs, and rab-
bits, and large animal category mostly goats, dogs, and 
primates [31–33]. Rodent models have inherent limita-
tions when compared to larger models, including rabbits. 
Rodents have smaller long-bones, more fragile cortex, 
and do not show Haversian-type remodeling in the cor-
tex [31]. Rabbits are considered the largest animals in 
the small animals category, and hence less susceptible to 
elaborate and exhaustive additional clearance require-
ments usually implemented by the central ethical com-
mittees. They are non-aggressive, easy to observe, have 
quicker vital capacity in terms of gestation and maturity, 
and can be locally bread [31–33]. The histology of bone in 
rabbits is not quite similar to bone in humans, and com-
poses of dense Haversian bone and layers primarily vas-
cular longitudinal canals [31–33]. However, similarities 
in bone mineral density and fracture toughness between 
rabbits and human have been reported in the literature 
[32–34]. An essential issue with rabbits that they express 
rapid skeletal metabolism and increased bone turno-
ver rate, mostly cortical remodeling when compared to 
primates and some rodents [31–33]. To properly simu-
late human in vivo environment, the rabbit model is an 
appropriate animal model for alveolar cleft experimen-
tal studies because the rabbit is reproducible, accurate, 
easy to house and handle, relatively easily anaesthetised, 
provides large enough area for testing and properly sized 
mammalian that can bear the trauma of surgery [32, 33].
The aim of this study was to develop a model in New 
Zealand White (NZW) rabbits, Oryctolagus cuniculus, 
to enable surgically creating of a healed skeletal alveolar 
defect extending to the nasal mucosa and the adjacent 
tooth structure as seen in human patients.
Methods
Osteological survey of New Zealand White rabbit skull (O. 
cuniculus)
A skull of a NZW rabbit was obtained from the ani-
mal stock library at RWTH Aachen University Hospital 
(Germany) for inspection of the anatomical landmarks 
(Fig. 1).
Microfocus computed tomography (Micro‑CT) for imaging 
survey
Imaging with Micro-CT of a rabbit skull were obtained 
of radiographic analysis of the skeletal anatomy for 
assessment of the feasibility of creating an alveolar cleft 
defect and planning of the cleft creation surgery. Images 
were evaluated using cross-sectional slices and rendered 
three-dimensional reconstruction (Fig. 2).
Postmortem pilot alveolar cleft creation surgery 
and Micro‑CT imaging
A pilot surgical operation of the planned procedure was 
conducted on a sacrificed rabbit head. There was no need 
for an animal ethical committee approval given that the 
procedure was performed on a sacrificed animal which was 
previously been used in another animal testing project. The 
cleft creation surgery was conducted according to the pro-
posed procedure (Fig. 3). Post-operative microfocus com-
puted tomography (Micro-CT) was obtained of the rabbit 
skull to evaluate the created postmortem defect (Fig. 4).
In‑vivo alveolar cleft creation surgery: animals, anesthesia, 
and housing
After evaluation of the correct position and volume of the 
cleft in the post-mortem pilot 16 8-week-old New Zea-
land White rabbits weighing 2.6–3.0 kg were operated in 
the same manner to prove the model in an in vivo setting. 
The procedure was conducted at the Animal Research 
Centre, Health Sciences Centre, Kuwait University. The 
project was subjected to strict animal testing protocol 
and the approval by the animal ethical committee at Ani-
mal Research Centre, Health Sciences Centre, Kuwait 
University. The rabbits were sedated 30  min prior to 
the experimental surgery with xylazine HCl 5 mg/kg by 
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intramuscular injection and subsequently anesthetized 
by intravenous injection of 35 mg/kg of ketamine HCl. To 
ensure a high standard of animal care, a veterinarian was 
administering the sedation, anesthesia, and care-taking 
of the animals following an already used methodology 
[35, 36]. The animals were kept in separate cages and fed 
pellets and water throughout the duration of the study. 
The rabbits were cared of accordingly per protocol and 
observed by veterinarian until the end of the study.
In‑vivo alveolar cleft creation surgery in NZW rabbits 
(n = 16)
Preparation of surgical sites in maxillary alveolus
The surgery was performed with the rabbits in a supine 
position and under sterile conditions. A linear mucosal 
incision approximately was performed 2 cm lateral to the 
left central incisor and along the curvature of the tooth, 
extending to the distobuccal angle of the left central inci-
sor, and then extended into the gingival margin of the 
left central incision on the facial aspect to the midline 
papilla. The gingiva and soft tissue were to expose the 
maxillary alveolus and the periodontal attachment of 
the central incisor tooth. Subsequently a flap was raised 
subperiosteally to expose the inferior nasal aperture. The 
nasal mucosa was freely protected and elevated using 
curved periosteal elevator taking care not to perforate 
the nasal mucosa. Lateral osteotomy along the lateral 
curvature of the left central incisor was performed using 
a rotary instrument with a round carbide bur to create a 
window exposing the root of the central incisor. The cen-
tral incisor was then gently luxated toward the weakened 
lateral wall using a small dental elevator and eventually 
extracted using a veterinarian dental extraction forceps 
for rodents. Further osteotomy was carried to remove the 
superior and inferior bony plates with rongeur forceps to 
expose the nasal mucosa without injuring the mucosa. 
Bone wax then applied to the bony walls of the defect 
and the oral mucosa was approximated and sutured with 
five zeros resorbable Vicryl suture (Vicryl, Ethicon, USA) 
only on the medial and lateral sides. The central part of 
the wound was left open creating a pocket overlooking 
the bony defect. The defect was packed at the end with 
oxidised cellulose (Surgicel, USA). The nasal mucosa was 
left intact throughout the surgical procedure. The ani-
mals were allowed a period of 8 weeks for healing of the 
defect and the creation of maxillary alveolar defect.
The same surgical preparation and the strict protocol 
was carried at the second stage to expose the alveolar 
defect in preparation of bone grafting. A submarginal 
incision is made in the alveolar defect to separate the oral 
from the nasal mucosa. The bony defect was exposed and 
bony walls were lightly freshened with a round diamond 
bur. The rabbits were fed soft diet ad lib directly after the 
surgery. The rabbits were cared of accordingly per proto-
col and watched by veterinarian until the end of the study 
after 3 months.
Post‑operative cone beam computed tomography of the 
alveolar clefts
Postoperative imaging with Cone Beam CT of the rab-
bit skull was obtained 8 weeks after cleft creation surgery 
(Fig. 8).
Fig. 1 Osteological survey of New Zealand White rabbit skull. Preserved skull of a NZW rabbit (Oryctolagus cuniculus) showing the depth and 
orientation of the maxillary incisor alveolus after removing the central incisor. The alveolus penetrates into the maxillary bone laterally with strong 
curvature toward the palatal shelf. The tooth extends just shorts of the extensively aerated maxillary sinus
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Results
Osteological survey of New Zealand White rabbit skull  
(O. cuniculus)
A visual inspection of a skull of NZW rabbit revealed that 
in the area of interest to our study, the anterior maxilla of a 
NZW rabbit harboured two paired central incisors and two 
paired accessory palatal incisors. The central incisor was 
prominent and is in the form of half a circle and the acces-
sory palatal incisor was smaller and roughly half the length 
of the central incisor. Examining a skull with an extracted 
central incisor revealed that the prominent tooth traversed 
the maxillary bone just below the nasal aperture leaving a 
thin layer of bone separating the alveolar socket from the 
nasal mucosa. The alveolar socket of an extracted central 
Fig. 2 Imaging survey. Micro-CT three-dimensional reconstruction of a preserved skull of a NZW rabbit showing the depth and morphology of the 
extraction socket. Coronal sections at the level of the central incisors show thin bony plates separating the tooth from the nasal cavity
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incisor formed a pocket-like cavity with a dimension of 
7–8  mm made it an ideal model for alveolar cleft studies 
once the superior and inferior bony plate was resected to 
create a continuous defect simulating what is commonly 
seen in patients with congenital alveolar cleft (Fig. 1).
Microfocus computed tomography (Micro‑CT) for imaging 
survey
Three-dimensional Micro-CT reconstruction of the rab-
bit skull and the Micro-CT imaging revealed high level of 
accuracy and clear view of the maxillary alveolar socket 
Fig. 3 Postmortem pilot alveolar cleft creation surgery. a–i Postmortem pilot alveolar cleft creation surgery of a sacrificed NZW rabbit showing 
the modification of the extraction socket to expose the nasal lining. The defect can be completely covered by mucosa to allow healing and enable 
mucosal coverage of the cleft surfaces
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Fig. 4 Postmortem imaging. Micro-CT imaging of the created cleft in a pilot postmortem surgery. Coronal view at the level of the anterior part of 
the extraction socket shows a complete cleft 8 mm wide extending from the oral cavity to the nasal cavity. Coronal view at the apical region of the 
extracted central incisor shows a residual defect with all bony walls intact
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for volume analysis and measurement of bony landmarks 
(Fig. 2).
Postmortem pilot alveolar cleft creation surgery 
and Micro‑CT imaging
Simulation of the alveolar cleft surgery on a sacrificed 
rabbit skull revealed the feasability of creating an ade-
quately sized defect. The defect could be easily extended 
to the nasal mucosa to simulate a real clinical defect. Soft 
tissue closure and suturing of the mucosa was readily 
performed (Fig. 3). Three-dimensional reconstruction of 
the defect revealed a triangular alveolar cleft defect with 
a width of 8  mm that extended to the nasal cavity with 
the apex of the defect posting posteriorly and toward the 
depth of the alveolar socket. This simulates the clinical 
findings in patients with alveolar cleft defect (Fig. 4).
In‑vivo alveolar cleft creation surgery in NZW rabbits
The surgery for each rabbit took between 15 and 30 min, 
and all procedures could be carried out during Ketamine 
anesthesia without endotracheal intubation (Fig. 5). In a 
few cases an extra injection of Ketamine was required. 
Bleeding was minor and not a clinical issue during or 
after the cleft creation surgery. The animals were active 
and behaved adequately immediately after the surgery. 
They all started eating already during the first days after 
surgery. The animals were fed ad  libitum well through-
out the study. All the rabbits survived during the 8 weeks 
postoperatively until day of the sacrifice (Figs. 6, 7). The 
methodology and results of this in  vivo-study will be 
reported more in detail in later separate papers.
Post‑operative computed tomography of the alveolar 
clefts
After 8 weeks healing, computed tomography was carried 
out in one animal. A three-dimensional reconstruction of 
the defect revealed a triangular alveolar cleft defect with 
a width of 8 mm and extending to nasal cavity with the 
apex of the defect posting posteriorly and toward the 
depth of the alveolar socket was verified (Fig. 8).
Discussion
Alveolar maxillary defects are unique defects with regard 
to their overlying soft tissues; the oral mucosa inside 
the mouth and the nasal mucosa as the nasal floor lin-
ing. The topography of such defect makes it susceptible 
Fig. 5 In-vivo alveolar cleft creation surgery. a–l In-vivo cleft creation surgery showing the modification of the extraction socket to expose the nasal 
lining. Distance material of bone wax and oxidized cellulose were used to keep the defect open and allow the mucosa to cover the cleft surfaces
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Fig. 6 Wound healing. Healing of the surgery site 1 week after surgery (a) and 3 weeks after surgery (b). c Healed cleft site 8 weeks after surgery 
and before exposure of the alveolar cleft for bone grafting. Note the fistula overlying the cleft side indicating the establishment of an underlying 
bone defect
Fig. 7 Grafting of the defect. a Healed alveolar cleft site 8 weeks after surgery and before grafting intervention. b Grafting intervention in the 
established alveolar cleft. c Final coverage of the cleft with oral mucosa. Complete coverage of the defect is achieved without wide mobilization of 
the soft tissue
Fig. 8 Postoperative imaging. a Cone Beam CT imaging of the created alveolar cleft after 8 weeks of healing shows a complete cleft extending 
from the oral cavity to the nasal cavity. b Alveolar cleft 8 weeks after grafting the defect with bone substitute material
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to two biologically distinctive anatomical compartments 
each with a particular bio-environment. The aim of alve-
olar bone grafting is to obtain a proper reestablishment 
of these anatomical structures and provide a new bone 
structure that are acceptable in regard to volume and 
bone quality. Utilization of an animal model with a healed 
alveolar cleft defect, which mimics the three dimensional 
morphology in human patients with cleft lip and palate 
and extending to the nasal mucosa, would be best model 
to test the healing pattern of bone graft materials and to 
establish the proper anatomical structure.
Proper grafting of alveolar cleft deformities is an essen-
tial step to re-establish the dental arch in patients with 
cleft palate. This depends on the type of the grafting 
material that aims to restore form, volume and the func-
tional establishment of a skeletal biological medium that 
would allow the eruption of the permanent teeth. Recent 
advances in tissue-engineered bone substitute materials 
and biomedical science have prompt further improve-
ments in existing testing animal models to better evaluate 
the osteogenic efficacy and healing efficiency of the new 
grafting materials [4–8, 37].
Several models have been proposed as alveolar cleft 
model for testing of tissue-engineered bone replacement 
material. These ranging from mice, rats, rabbits, cats, 
dogs, swines, goats, sheep and monkeys [4, 9–24]. Prior 
description on rats models were able to create defects 
simulating alveolar defects because of their ease of han-
dling and cost effectiveness, however, these defects tend 
to be significantly smaller in volume than human alveolar 
defects making it technically challenging to properly per-
form the grafting testing procedure [13, 17, 18, 21, 24].
The first description in the literature on an animal 
model for creating an alveolar cleft was reported by Har-
vold. He described the creation of an alveolar and palatal 
cleft 2 mm wide in two Rhesus monkeys [38]. The skeletal 
metabolism and bony macrostructure is small rodents 
tends to be far more active than bigger mammals and this 
may compromise the applicability of the animal testing 
findings. Thus bigger animals were considered a closer 
models to the human counterparts and able of mimick-
ing skeletal defects and several attempts have been trying 
to describe further surgical techniques and modifications 
on previously reported methodologies mostly on mon-
keys and dog models [11, 12]. In recent years, attempts 
have been made to create more effective, economical and 
smaller animals to create acceptable alveolar cleft defects. 
Despite the increased descriptions of several animal 
models for alveolar bone grafting materials testing, most 
of the in vivo animal models using small animals were not 
able to function as reliable alveolar cleft model simulating 
that in human. This is mostly because of the limited ana-
tomical size in these models which lead to difficulties in 
handling intraoral surgical procedures. This results in a 
compromise in designing and establishing proper sizable 
defects mimicking three-dimensional triangular defect 
extending to the nasal mucosa and the adjacent tooth as 
seen in human patients [12, 18, 39].
Most current reports in the literature illustrated the 
creation of simple non-anatomical defects in the maxilla 
of small animals by creating a maxillary or palatal window 
to establish a communication between the oral cavity and 
the nasal cavity, as described by Nguyen et  al., Raposo-
Amaral et al., Mostafa et al., Takano-Yamamoto et al. and 
Kim et  al. in rats, and by Sawada et  al. and Puumanen 
et al. in rabbits [17, 18, 21, 22, 39–41]. Xu et al. described 
the establishment of a cleft model in rats by extracting 
a molar tooth and applying bone wax [24]. Their model 
has succeeded in controlling the osseous healing process 
but the anatomical location of the defect does not corre-
spond to a tridimensional maxillary alveolar cleft defects 
as encountered clinically. In some studies the defects 
were created and were not allowed to heal to establish a 
true non-healing critical defect and the insertion of the 
grafting material was performed simultaneously during 
the cleft creation surgery as seen in the models described 
by Takano-Yamamoto et  al., Sawada et  al., Puumanen 
et  al., Pilanci et  al. and Kim et  al. [20, 22, 39–41]. The 
immediate grafting of the created defect leads to mask-
ing the effect of the native bone healing, and thus it 
would be difficult to attribute the new bone formation to 
the potential of the inserted graft rather than the native 
bone healing. El-Bokle et al. described a rabbit model for 
creating an alveolar cleft defect by extracting the central 
and lateral incisor and creating a wide defect and split-
ting the nasal mucosa to suture it the oral mucosa and 
leaving 1 cm defect [11]. In our opinion, a wide skeletal 
defect is plausible in creating alveolar cleft but 1 cm oro-
nasal communication rarely correlates with clinical sce-
narios. A meta-analysis by Bykowski et al. evaluated the 
rate of oronasal fistula after primary cleft repair surgery 
and reported that most of the significant oro-nasal fis-
tulas leading to clinical symptoms occurred posterior to 
the incisive foramen with the highest incidence at the 
soft-hard palate junction, and the lowest incidence of the 
fistula occurring at the maxillary alveolus [42]. In addi-
tion, splitting and suturing the nasal mucosa in a rabbit 
model is challenging given the anatomical limitation and 
would significantly increase the operating time and may 
compromise the health of the animal due to increased 
anesthetic requirement, compromise oral intake postop-
eratively, and increase the risk of aspiration and bleeding 
into the nasal cavity.
In our model we were able to achieve a reliable and 
consistent alveolar cleft in the maxillary front region and 
extending to the nasal mucosa, along with a nearby tooth 
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which simulates the local anatomy of maxillary alveolar 
cleft in cleft lip and palate patients. Extracting an inci-
sor by removing bone lateral to the incisor and luxate the 
tooth laterally has recently been described by Maslamani 
et  al. in an experimental tooth replantation study [43]. 
Due to the extremely curved rabbit incisor it is not pos-
sible to extract through the longitudinal axis of the tooth 
but instead through lateral luxation after some bone 
removal.
Preparation of the cleft by keeping the nasal mucosa 
intact was possible and the surgery can be carried in 
15–20  min and without general inhalation anesthesia 
or intubation, and without major risk of aspiration. The 
control of the space preventing it from bony ingrowth 
with simple bone wax seems to be consistently efficient 
in limiting bone healing, and the oxidized cellulose help 
in maintaining a spaced and aiding in prevent the col-
lapse of the defect by extensive fibrous tissue. Allowing 
8 weeks for cleft creation surgery seems to be enough to 
assume critically sized defect.
Our study shows that it is possible to produce a reliable 
and predictable animal model in rabbits to perform alve-
olar bone grafting. The surgical site area is of similar size 
and in the same region as that of pediatric population 
in human subjects, and the procedure does not require 
magnifying apparatus or micro instruments.
Conclusions
A simple and predictable rabbit model with alveolar cleft 
for the clinical testing of e.g. tissue-engineering bone 
substitute materials can be created by following the exist-
ing anatomy and extraction of a central incisor tooth, 
modification of the extraction socket by extending it to 
the nasal mucosa, and the application of simple bone wax 
and oxidized cellulose material to help modulating the 
healing phase in the cleft area and avoid rapid bone gen-
eration and filling of the defect. Allowing 8 weeks of heal-
ing yields a predictable and good sized defect that can be 
used for later grafting procedures.
Abbreviation
NZW: New Zealand White rabbit.
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